These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 16208122)

  • 1. Letter: Comparing first-line infliximab and vedolizumab for ulcerative colitis-it depends on how you use the drug. Authors' reply.
    Bokemeyer B; Plachta-Danielzik S
    Aliment Pharmacol Ther; 2024 Jan; 59(1):142-143. PubMed ID: 37924219
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment options for refractory ulcerative colitis: Small molecules, big effects.
    Marafini I; Roseira J; Duijvestein M
    United European Gastroenterol J; 2024 Jun; 12(5):539-540. PubMed ID: 38713604
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Should ulcerative colitis be monitored more or less invasively?
    Laharie D
    Aliment Pharmacol Ther; 2024 Mar; 59(5):721-722. PubMed ID: 38349702
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of infliximab in ulcerative colitis: further questions.
    Lees CW; Shand AG; Penman ID; Satsangi J; Arnott ID
    Inflamm Bowel Dis; 2006 Apr; 12(4):335-7. PubMed ID: 16633056
    [No Abstract]   [Full Text] [Related]  

  • 5. Infliximab therapy for ulcerative colitis: many unanswered questions.
    Present DH
    Am J Gastroenterol; 2001 Aug; 96(8):2294-6. PubMed ID: 11513164
    [No Abstract]   [Full Text] [Related]  

  • 6. Is infliximab effective for induction of remission in patients with ulcerative colitis?
    Lichtenstein GR
    Inflamm Bowel Dis; 2001 May; 7(2):89-93. PubMed ID: 11383596
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biological therapy in children with inflammatory bowel syndrome (clinical cases)].
    Alieva ÉI
    Eksp Klin Gastroenterol; 2014; (1):110-2. PubMed ID: 25518466
    [No Abstract]   [Full Text] [Related]  

  • 8. Infliximab: new indication. Ulcerative colitis: caution is needed due to long-term risks.
    Prescrire Int; 2007 Oct; 16(91):194. PubMed ID: 17926832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab for ulcerative colitis.
    Chey WY; Shah A
    J Clin Gastroenterol; 2005; 39(10):920; author reply 920. PubMed ID: 16208122
    [No Abstract]   [Full Text] [Related]  

  • 10. Emerging biologic therapies in inflammatory bowel disease.
    Lim WC; Hanauer SB
    Rev Gastroenterol Disord; 2004; 4(2):66-85. PubMed ID: 15184826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biologics treatment for ulcerative colitis].
    Nagahori M; Fujii T; Saito E; Ohtsuka K; Watanabe M
    Nihon Shokakibyo Gakkai Zasshi; 2013 Nov; 110(11):1909-15. PubMed ID: 24189818
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ulcerative colitis and anti-TNFalpha].
    Nancey S; Moussata D; Flourié B
    Gastroenterol Clin Biol; 2007 Jan; 31(1):84-7. PubMed ID: 17273136
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.